Dr Nicole Parker

Head, Cerebral Tumour Research
Kolling Institute of Medical Research, Northern Clinical School

E25 - Royal North Shore Hospital
The University of Sydney
NSW 2006 Australia

T: +61 2 9926 4765
F: +61 2 9926 8484


2014 | 2013 | 2010


  • Tsang, V., Dwight, T., Benn, D., Meyer-Rochow, G., Gill, A., Sywak, M., Sidhu, S., Veivers, D., Sue, C., Robinson, B., Clifton-Bligh, R., Parker, N. (2014), Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours. Endocrine-Related Cancer. 21(3), 415-426. [Abstract]


  • Parker, N., Correia, N., Crossley, B., Buckland, M., Howell, V., Wheeler, H. (2013), Correlation of MicroRNA 132 Up-regulation with an Unfavorable Clinical Outcome in Patients with Primary Glioblastoma Multiforme Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide Chemotherapy. Translational Oncology. 6(6), 742-748. [Abstract]


  • Gill, A., Chou, A., Vilain, R., Clarkson, A., Lui, M., Jin, R., Tobias, V., Samra, J., Goldstein, D., Smith, C., Sioson, L., Parker, N., Smith, R., Sywak, M., Sidhu, S., Wyatt, J., Robinson, B., Eckstein, R., Benn, D., Clifton-Bligh, R. (2010), Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types. American Journal of Surgical Pathology. 34(5), 636-644. [Abstract]